Literature DB >> 22473867

Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.

Nirali N Shah1, Ulrike Bacher, Terry Fry, Katherine R Calvo, Maryalice Stetler-Stevenson, Diane C Arthur, Roger Kurlander, Kristin Baird, Barbara Wise, Sergio Giralt, Michael Bishop, Nancy M Hardy, Alan S Wayne.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22473867      PMCID： PMC3454494          DOI： 10.1002/ajh.23174

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  95 in total

1.  New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.

Authors:  G Socié; R E Curtis; H J Deeg; K A Sobocinski; A H Filipovich; L B Travis; K M Sullivan; P A Rowlings; D W Kingma; P M Banks; W D Travis; R P Witherspoon; J Sanders; E S Jaffe; M M Horowitz
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

2.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.

Authors:  J Douglas Rizzo; John R Wingard; Andre Tichelli; Stephanie J Lee; Maria Teresa Van Lint; Linda J Burns; Stella M Davies; James L M Ferrara; Gérard Socié
Journal:  Biol Blood Marrow Transplant       Date:  2006-02       Impact factor: 5.742

3.  Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies.

Authors:  María Díez-Campelo; José Antonio Pérez-Simón; Jose Pérez; Miguel Alcoceba; Juan Richtmon; Belén Vidriales; Jesús San Miguel
Journal:  Am J Hematol       Date:  2009-03       Impact factor: 10.047

4.  Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Authors:  Alan List; Gordon Dewald; John Bennett; Aristotle Giagounidis; Azra Raza; Eric Feldman; Bayard Powell; Peter Greenberg; Deborah Thomas; Richard Stone; Craig Reeder; Kenton Wride; John Patin; Michele Schmidt; Jerome Zeldis; Robert Knight
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

5.  Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.

Authors:  Ulrich Germing; Corinna Strupp; Andrea Kuendgen; Shadi Isa; Sabine Knipp; Barbara Hildebrandt; Aristoteles Giagounidis; Carlo Aul; Norbert Gattermann; Rainer Haas
Journal:  Haematologica       Date:  2006-12       Impact factor: 9.941

6.  Myelodysplastic syndrome of donor origin subsequent to successful treatment of myeloid/NK-cell precursor leukaemia with allogeneic PBSCT: two very rare conditions in one patient.

Authors:  C Beck; A Humpe; S Harder; M Schmid; H A Horst
Journal:  Ann Hematol       Date:  2005-03-22       Impact factor: 3.673

7.  Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.

Authors:  D A Carney; D A Westerman; C S Tam; A Milner; H M Prince; M Kenealy; M Wolf; E H Januszewicz; D Ritchie; N Came; J F Seymour
Journal:  Leukemia       Date:  2010-10-21       Impact factor: 11.528

8.  Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.

Authors:  Jakob R Passweg; Aristoteles A N Giagounidis; Mathew Simcock; Carlo Aul; Christiane Dobbelstein; Michael Stadler; Gert Ossenkoppele; Wolf-Karsten Hofmann; Kristina Schilling; André Tichelli; Arnold Ganser
Journal:  J Clin Oncol       Date:  2010-12-13       Impact factor: 44.544

9.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  David L Porter; Edwin P Alyea; Joseph H Antin; Marcos DeLima; Eli Estey; J H Frederik Falkenburg; Nancy Hardy; Nicolaus Kroeger; Jose Leis; John Levine; David G Maloney; Karl Peggs; Jacob M Rowe; Alan S Wayne; Sergio Giralt; Michael R Bishop; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-10       Impact factor: 5.742

10.  Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.

Authors:  Elias Jabbour; Sergio Giralt; Hagop Kantarjian; Guillermo Garcia-Manero; Madan Jagasia; Partow Kebriaei; Leandro de Padua; Elizabeth J Shpall; Richard Champlin; Marcos de Lima
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860
View more
  4 in total

1.  Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature.

Authors:  Komal Galani Deshmukh; Katalin Kelemen
Journal:  Life (Basel)       Date:  2022-04-08

2.  A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.

Authors:  Kai-Xun Hu; Qi-Yun Sun; Mei Guo; Jun-Xiao Qiao; Chang-Lin Yu; Jian-Hui Qiao; Zheng Dong; Wan-Jun Sun; Hong-Li Zuo; Ya-Jing Huang; Bo Cai; Hui-Sheng Ai
Journal:  Stem Cells Transl Med       Date:  2016-02-02       Impact factor: 6.940

3.  Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3+ T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome Patients.

Authors:  Yan Huang; Minghua Hong; Zhigang Qu; Weiyan Zheng; Huixian Hu; Linjie Li; Ting Lu; Ying Xie; Shuangwei Ying; Yuanyuan Zhu; Lizhen Liu; Weijia Huang; Shan Fu; Jin Chen; Kangli Wu; Mingsuo Liu; Qiulian Luo; Yajun Wu; Fang He; Jingcheng Zhang; Junyu Zhang; Yu Chen; Minlei Zhao; Zhen Cai; He Huang; Jie Sun
Journal:  Front Oncol       Date:  2021-10-13       Impact factor: 6.244

4.  Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?

Authors:  Mirko Farina; Simona Bernardi; Lisa Gandolfi; Camilla Zanaglio; Enrico Morello; Alessandro Turra; Tatiana Zollner; Doriana Gramegna; Benedetta Rambaldi; Federica Cattina; Nicola Polverelli; Michele Malagola; Domenico Russo
Journal:  Front Oncol       Date:  2020-10-14       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.